Olivier has had extensive experience in senior positions within the Financial Industry with firms such as Drexel Burnham Lambert & Moseley and Hallgarten Estabrook & Weedon. Olivier is registered with the FCA as CF30, Dr Debarge received his BA, MA and PHD from Oxford University.
Compliance and Risk Officer
Tim works on the Operations and Client Services arm of Perinvest where he started in 2001. Prior to starting at Perinvest he was working for a London based financial recruitment firm where he was account manager for a large media firm.
Recently, Tim was made Compliance Officer for Perinvest (UK) Limited.
Michael joined Perinvest in 2003. Previously he was a partner at Pinchin Denny before their takeover by Morgan Grenfell in 1986. He joined Shearson Lehman in 1989 after which he was with Nomura International. Prior to joining Perinvest he joined Edgar Astaire & co in 1993 which became Soros Funds Limited. Michael is a Chartered Fellow of the Chartered Institute for Securities & Investment.
Nabil started his career in 1999 at SG Cowen, as a financial analyst for the healthcare M&A division (NY). Between 2001-2005, Nabil was an associate at Bioam, a €51m VCF specialized in Biotech.
In 2011, Nabil founded Biotech Promise, a specialized investment fund dedicated to listed biotech and medtech companies.
Director Business Development
Anthony joined Perinvest in 2017. He began his career 1996 at Union Bancaire Privee in London where he worked on the proprietary trading desk as a portfolio manager on the fixed income side initially followed by the equity side. In 2005 he co-founded a boutique hedge fund called Ruby Capital Partners where he was a Portfolio Manager and head of trading. In 2012 he joined Cologny Advisors, where he was partner and head of business development helping to raise AUM from $20m to over $300m.